BACK TO ALL REFERENCES
Smartscope-X: Affordable, accessible and automatic screening solution for diabetic retinopathy
Smartscope-X solution consists of 3 main components: a low-cost handheld camera, an automated screening algorithm and cloud service for eyeground images.
€1.97 m
in funding
Key numbers
About the project
Diabetic retinopathy is a diabetic condition, the most frequent cause of preventable blindness in working-aged adults, affecting people with all types of diabetes. Current screening is costly, takes time and needs to be done by an ophthalmologist.
This solution consists of 3 main components: a low-cost handheld camera, an automated screening algorithm and cloud service for eyeground images. The project leads the way by making Smartscope-X the leading solution for diabetic retinopathy screening. It supports Optomed’s vision to provide affordable eye screenings to everyone.
Impact of the project:
Smartscope-X is a low-cost & portable solution, and also suitable in areas with limited access to screening, for example in developing countries.
Funding instrument Horizon 2020 SME instrument phase 2
Spinverse’s role
Spinverse helped by providing support in project preparation, including help in defining the scope, matching the call and assisting in the funding proposal writing.
After a positive decision from the EU Commission, Spinverse supported Optomed in the project negotiation phase..
Supporting the UN Sustainable Development Goals
We share what we learn
Read our latest news on our references
